Accenture to Help Santen Pharmaceutical Build a Global Intelligent Enterprise Platform on SAP® S/4HANA® to Drive Its Digita...
30 Octubre 2019 - 7:59PM
Business Wire
Accenture (NYSE: ACN) has been selected to help Santen
Pharmaceutical Co., Ltd. (Santen), an ophthalmic pharmaceutical
company headquartered in Japan, build a global intelligent
enterprise platform that will drive the company’s digital
transformation.
As part of the program, Accenture will help migrate Santen’s key
data and processes for supply chain management, finance &
accounting and other enterprise operations to SAP S/4HANA®. The new
system will consolidate information at all its locations across
more than 20 countries and regions.
For the system migration, Accenture will use Accenture
myConcerto, an insight-driven, digitally integrated platform that
helps harmonize SAP solutions and technologies, enabling Santen to
develop a common system template for all global locations before
beginning implementation. Santen will begin implementing SAP
S/4HANA at locations across Southeast Asia, with the goal of
ultimately rolling it out across other locations worldwide.
Accenture is assembling a global team for the project that will
include professionals from Japan, the U.S., India and China.
"As a specialized company dedicated to ophthalmology, Santen
needs to further standardize and improve the efficiency of business
processes at all our group locations to continue our sustainable
growth and contributions to patients all over the world," said
Noriaki Yamamoto, corporate officer, CIO, head of information
systems division at Santen. "This migration project will be the
foundation of our growth, and we selected Accenture as a partner
based on its industry expertise and extensive experience with SAP
S/4HANA implementation."
Osamu Yamamoto, a managing director in Accenture’s Life Sciences
practice in Japan, said, "Accenture was recently named as a Leader
by Gartner in the SAP S/4HANA Application Services, Worldwide Magic
Quadrant and has conducted many global transformation projects
based on SAP technologies within the pharmaceutical industry. We
are excited to be able to help Santen in its transformation to a
digital, intelligent enterprise and accelerate its growth.”
About Accenture
Accenture is a leading global professional services company,
providing a broad range of services and solutions in strategy,
consulting, digital, technology and operations. Combining unmatched
experience and specialized skills across more than 40 industries
and all business functions — underpinned by the world’s largest
delivery network — Accenture works at the intersection of business
and technology to help clients improve their performance and create
sustainable value for their stakeholders. With 492,000 people
serving clients in more than 120 countries, Accenture drives
innovation to improve the way the world works and lives. Visit us
at www.accenture.com.
SAP, SAP S/4HANA and other SAP products and services mentioned
herein as well as their respective logos are trademarks or
registered trademarks of SAP SE in Germany and other countries.
Please see https://www.sap.com/copyright for additional trademark
information and notices.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20191030005005/en/
Shigeo Masuda Accenture +81 45 330 7157
accenture.jp.media@accenture.com
Accenture (NYSE:ACN)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024
Accenture (NYSE:ACN)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024